financetom
Business
financetom
/
Business
/
Low-cost airline Allegiant's Q3 adjusted EPS misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Low-cost airline Allegiant's Q3 adjusted EPS misses estimates
Nov 4, 2025 1:28 PM

Overview

* Allegiant Q3 2025 adjusted EPS of $2.09 misses analyst expectations

* Company Q3 revenue flat at $561.9 mln, missing analyst expectations

* Allegiant maintains 99.9% completion factor, records 4.6 mln passengers in Q3

Outlook

* Allegiant raises full-year airline-only EPS guidance to over $4.35

* Company expects double-digit Q4 operating margin

* Allegiant anticipates full-year ASM growth of ~12.5%

Result Drivers

* OPERATIONAL PERFORMANCE - Allegiant maintained a 99.9% completion factor and transported a record 4.6 mln passengers in Q3

* COST DISCIPLINE - CASM excluding fuel decreased by 4.7% over the prior year, highlighting cost control efforts

* SEASONAL WEAKNESS - Q3 is the seasonally weakest quarter, leading to a moderate operating loss at the favorable end of guidance

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $561.90 $576.70

Revenue mln mln (11

Analysts

)

Q3 Miss -$2.09 -$1.98

Adjusted (13

EPS Analysts

)

Q3 EPS -$2.41

Q3 Net -$43.60

Income mln

Q3 -$27.20

Operatin mln

g Income

Q3 -$52.20

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the airlines peer group is "buy."

* Wall Street's median 12-month price target for Allegiant Travel Co ( ALGT ) is $65.00, about 4.7% above its November 3 closing price of $61.93

* The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Developer fee cuts not passed on to EU users, Apple says
Developer fee cuts not passed on to EU users, Apple says
Nov 12, 2025
BRUSSELS, Nov 12 (Reuters) - Lower developer fees implemented by Apple ( AAPL ) to comply with European Union tech regulations have not reduced prices for users, the iPhone maker said on Wednesday, renewing its criticism of Europe's efforts to rein in its market power. Last year, in response to the bloc's Digital Markets Act, Apple ( AAPL ) allowed...
Loar Cashes In On Soaring Jet Orders And Global Travel Surge
Loar Cashes In On Soaring Jet Orders And Global Travel Surge
Nov 12, 2025
Loar Holdings Inc. ( LOAR ) reported record third-quarter 2025 results, beating adjusted earnings estimates but narrowly missing revenue expectations, as strong demand from the aerospace and defense sectors fueled growth. The company’s stock traded higher following the announcement, reflecting investor optimism over raised guidance and record margins. Adjusted earnings per share came in at 35 cents, topping the 22-cent...
Rocket Lab Faces Modest Neutron Delay but Strong Electron Demand, Morgan Stanley Says
Rocket Lab Faces Modest Neutron Delay but Strong Electron Demand, Morgan Stanley Says
Nov 12, 2025
11:04 AM EST, 11/12/2025 (MT Newswires) -- Rocket Lab ( RKLB ) continues to see robust demand for its Electron rocket, though a modest delay in the first Neutron launch highlights ongoing development risks, Morgan Stanley said Wednesday in a report. The brokerage said Neutron's first flight is now expected in 2026, pushing out program spending and raising total development...
--AbbVie Severs Ties With Google-Backed Aging Research Biotech, STAT+ Reports
--AbbVie Severs Ties With Google-Backed Aging Research Biotech, STAT+ Reports
Nov 12, 2025
11:07 AM EST, 11/12/2025 (MT Newswires) -- Price: 228.67, Change: +3.50, Percent Change: +1.55 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved